Cladribine tablets are a cost-effective strategy in high-disease activity relapsing multiple sclerosis patients in Iran

Background: Cladribine tablets are the foremost oral immune-reconstitution therapy for high disease activity relapsing multiple sclerosis (HDA-RMS). We aimed to assess the cost-effectiveness of cladribine tablets compared to natalizumab in patients with HDA-RMS in Iran. Methods: A 5-year cohort-base...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayati, Nayyereh, Fleifel, Lora, Sharifi, Shahdak, Sahraian, Mohammad Ali, Nikfar, Shekoufeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984780/
http://dx.doi.org/10.18502/cjn.v20i3.7690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984780/
http://dx.doi.org/10.18502/cjn.v20i3.7690

Ejemplares similares